Cardurion Pharmaceuticals
Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics
80 employees · est. 2017 · Burlington, United States
Panacos Pharmaceuticals
Innovative solutions in the fight against HIV and other viral diseases using advanced small-molecule oral drugs
est. 1999
Panacos Pharmaceuticals is the older company (2017 vs 1999).
Side-by-Side Comparison
| Metric | Cardurion Pharmaceuticals | Panacos Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2017 | 1999 older |
| Headquarters | ||
| Headquarters | Burlington, United States | Not tracked yet |
| Employees | ||
| Employees | 80 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $603.20M | $58.30M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | Research and Development of Cardiovascular Drugs, Clinical Programs in PDE9 and CaMKII, In-house Drug Discovery, Clinical Study Evaluation | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Cardiovascular Disease, Healthcare Providers, Pharmaceutical Companies, Biotechnology Investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardurion Pharmaceuticals, Cardiac Myocyte Signaling Pathways, PDE9 Inhibition, CaMKII Inhibition, Cardiovascular Therapeutics, Heart Failure Treatment, Biotechnology Company, Clinical Programs, Cardiovascular Diseases, Partnerships, Investors, Bain Capital, Takeda Pharmaceutical, Astellas, Drug Discovery, Boston-based Company | Drug Discovery, Small-Molecule Drugs, Oral Drugs, Viral Diseases Treatment, HIV Treatment, Virus Life Cycle, Maturation Inhibition, Fusion Inhibition, Pharmaceutical Research, Innovative Drugs, HIV Research, Biotech Startups, Healthcare Innovation, Medical Technology |
| Website | ||
| Website | cardurion.com | panacos.com |
About Cardurion Pharmaceuticals
Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for its expertise in translating cardiac myocyte signaling pathways into groundbreaking therapeutics, s...
About Panacos Pharmaceuticals
Panacos Pharmaceuticals is a biotechnology company founded in 1999 that focuses on developing innovative small-molecule oral drugs to combat HIV and other viral diseases. The company's research emphasizes unique targets in the virus life cycle, including maturation and fusion of the virus. With a pr...
We will tell you when either one moves
BounceWatch watches Cardurion Pharmaceuticals and Panacos Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cardurion Pharmaceutic... and Panacos Pharmaceutical... — by email.
Frequently Asked Questions
Compare Cardurion Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cardurion Pharmaceuticals on 12 Sep 2024, and Panacos Pharmaceuticals on 25 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.